# FDA Inspection 696611 - Lifebanc - November 02, 2010

Source: https://www.keypedia.com/records/fda_inspections/lifebanc/ab9bf3da-7d75-49f8-8e44-e58150d0459e
Source feed: FDA_Inspections

> FDA Inspection 696611 for Lifebanc on November 02, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 696611
- Company Name: Lifebanc
- Inspection Date: 2010-11-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1314576 - 2026-04-21](https://www.keypedia.com/records/fda_inspections/lifebanc/84411018-73b1-4875-b72b-4f72df6713a1)
- [FDA Inspection 1191143 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/lifebanc/f2357d77-3efc-4707-ab49-2f842a44fa1e)
- [FDA Inspection 1191143 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/lifebanc/41bc7668-542b-4588-91a5-f89230786602)
- [FDA Inspection 1191143 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/lifebanc/c231fa9d-e332-488c-88a4-64c2b30d6890)
- [FDA Inspection 1111717 - 2019-11-22](https://www.keypedia.com/records/fda_inspections/lifebanc/72e419e1-da11-4fbe-a22f-4731c90bdfeb)

Company: https://www.keypedia.com/companies/lifebanc/b527a94f-5087-4dea-8a2d-e6b69fadd8f5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d